People | April 11, 2025
Zeon Lifesciences appoints GK Sharma as Group Technical Director
Sharma brings a wealth of expertise in optimizing manufacturing processes for fermentation-based APIs and sterile injectables
Sharma brings a wealth of expertise in optimizing manufacturing processes for fermentation-based APIs and sterile injectables
The inspection, conducted from March 17 to March 21, 2025, concluded with one observation in Form 483
Everolimus TFOS is a kinase inhibitor indicated in adult and paediatric patients aged one year and older with tuberous sclerosis complex for the treatment of subependymal giant cell astrocytoma
The inspection, which is a routine part of the FDA's regulatory oversight, evaluates compliance with Good Manufacturing Practices and other regulatory requirements.
The successful completion of RRA assessment by the USFDA, would enable company to open up its business in the USA market
Esketamine hydrochloride is a vital drug to be used for treating mental illness and is likely to significantly impact the LATAM market
The approved product has an estimated market size of US$ 268 million for the twelve months ending June 2024, according to IQVIA
Rusan’s API facility in Ankleshwar is GMP approved by other stringent international agencies as well
Eugia Pharma Specialities receives 7 observations from USFDA for Unit II
Before joining Gland, Loomba was associated with Shalina Labs, Harman Finochem, Aurobindo Pharma, Sun Pharmaceuticals and Ranabaxy Laboratories.
Subscribe To Our Newsletter & Stay Updated
